Latent view analytics Limited has received an ESG rating of 70 from NSE Sustainability Ratings and Analytics Limited (NSE ESG), as disclosed to stock exchanges on April 03, 2026. The communication regarding this rating was made by NSE ESG on April 02, 2026.

ESG Rating Details

The company received the ESG rating through an independent assessment process. Key aspects of this rating include:

Independent Assessment Process

The company clarified that it had not engaged NSE ESG for obtaining this ESG rating. Instead, NSE ESG independently prepared the assessment report based on data pertaining to the company that is available in the public domain. This approach demonstrates NSE ESG's methodology of conducting unsolicited evaluations using publicly accessible information.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. This regulatory framework mandates companies to inform stock exchanges about material developments, including ESG ratings.

The communication was signed by P. Srinivasan, Company Secretary and Compliance Officer of Latent View Analytics Limited, and was addressed to both BSE Limited and National Stock Exchange of India Limited for their information and records.

LatentView Analytics Limited has announced a strategic $3 million investment in Healtheon AI INC through its US subsidiary, marking the company's expansion into the AI-driven healthcare revenue cycle management sector. The investment was completed via Simple Agreement for Future Equity (SAFE) Notes, positioning LatentView as a strategic partner in the emerging agentic AI healthcare space.

Investment Structure and Timeline

LatentView Analytics Corporation, the New Jersey-incorporated wholly owned subsidiary, executed the SAFE Notes investment targeting Healtheon AI INC, a Delaware Corporation incorporated on March 20, 2026. The transaction represents a single-tranche investment completed on April 02, 2026.

Strategic Partnership and Market Focus

Healtheon AI specializes in agentic AI framework for Revenue Cycle Management services, deploying specialized, role-based AI agents in a decentralized, fault-tolerant system designed for healthcare finance complexity. The platform handles eligibility verification, prior authorization, medical coding, claims processing, and denial remediation with real-time processing capabilities.

"This investment is a strategic step forward in line with our AI vision of prioritizing advanced technology and proven expertise to deliver maximum value to our clients," said Rajan Sethuraman, CEO of LatentView Analytics. "With this investment, we are not only investing in healthcare; we are investing in an Agentic AI solution that solves a healthcare problem."

Technology Integration and Synergies

The partnership combines Healtheon AI's autonomous, agentic AI innovations purpose-built for healthcare with LatentView's horizontal analytics expertise. Unlike traditional automation tools, Healtheon AI's architecture deploys AI agents that integrate seamlessly with human teams to navigate clinical, financial, and regulatory workflows.

Executive Perspectives

"We are thrilled to welcome LatentView as an investor and strategic partner," said Dr. Nick van Terheyden, CEO of Healtheon AI. "LatentView is a leader in the data analytics and AI space, and they have a clear, strategic vision to bring the latest in AI to their clients."

Rajan Venkatesan, CFO of LatentView Analytics, emphasized the investment aligns with the company's build-invest-partner approach to become an AI-first and AI-led organization, noting significant synergies from the partnership.

Regulatory Compliance and Future Conversion

The disclosure was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The SAFE investment structure provides future conversion rights into SAFE Preferred Stock, triggered by future equity financing events or other agreed triggers. The investment falls outside LatentView's main line of business but aligns with its technology focus, with no related party transactions involved.